CDMO News
NorthStar and BWXT Collaborate on Critical Cancer Treatment Isotope
NorthStar Medical Radioisotopes LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc., have entered into a Master Services Agreement (MSA) to facilitate the production of actinium-225 (Ac-225). This isotope is crucial for killing cancer cells while minimising damage to healthy
23 July 2024